Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01896947




Registration number
NCT01896947
Ethics application status
Date submitted
8/07/2013
Date registered
11/07/2013
Date last updated
1/10/2024

Titles & IDs
Public title
3T MRI Versus MR Arthrogram in SLAP Lesions
Scientific title
Three Tesla Magnetic Resonance Imaging Compared to Magnetic Resonance Arthrogram in Diagnosing Superior Labrum Anterior Posterior (SLAP) Lesions
Secondary ID [1] 0 0
SLAP MR study
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Superior Labrum Anterior Posterior Lesion 0 0
Condition category
Condition code

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Diagnosis / Prognosis - MRI

MRI and MRA group - All patients will receive 3T MRI and MR arthrogram


Diagnosis / Prognosis: MRI
evaluating to see if 3T MRI is as effective as MR arthrogram to diagnose labral pathology

Intervention code [1] 0 0
Diagnosis / Prognosis
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Sensitivity 3T MRI
Timepoint [1] 0 0
3 months
Primary outcome [2] 0 0
Specificity 3T MRI
Timepoint [2] 0 0
3 months
Primary outcome [3] 0 0
Positive predictive value 3T MRI
Timepoint [3] 0 0
3 months
Primary outcome [4] 0 0
Negative predictive value 3T MRI
Timepoint [4] 0 0
3 months
Primary outcome [5] 0 0
Sensitivity MRA
Timepoint [5] 0 0
3 months
Primary outcome [6] 0 0
Specificity MRA
Timepoint [6] 0 0
3 months
Primary outcome [7] 0 0
Positive predictive value MRA
Timepoint [7] 0 0
3 months
Primary outcome [8] 0 0
Negative predictive value MRA
Timepoint [8] 0 0
3 months

Eligibility
Key inclusion criteria
* SLAP lesion
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Skeletally immature
* Previous SLAP lesion on ipsilateral side
* Implants contraindicated for MRI

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Withdrawn
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Michigan

Funding & Sponsors
Primary sponsor type
Other
Name
Henry Ford Health System
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Stephanie Muh, MD
Address 0 0
Henry Ford Hospital
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.